| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS44028873 | HTLV-1 | ENSG00000151834.16 | protein_coding | GABRA2 | No | No | 2555 | E9PBQ7 P47869 |
| TVIS44016273 | HTLV-1 | ENSG00000151834.16 | protein_coding | GABRA2 | No | No | 2555 | E9PBQ7 P47869 |
| TVIS44014174 | HTLV-1 | ENSG00000151834.16 | protein_coding | GABRA2 | No | No | 2555 | E9PBQ7 P47869 |
| TVIS44044885 | HTLV-1 | ENSG00000151834.16 | protein_coding | GABRA2 | No | No | 2555 | E9PBQ7 P47869 |
| TVIS44038494 | HTLV-1 | ENSG00000151834.16 | protein_coding | GABRA2 | No | No | 2555 | E9PBQ7 P47869 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | GABRA2 |
|---|---|
| DrugBank ID | DB04903 |
| Drug Name | Pagoclone |
| Target ID | BE0000381 |
| UniProt ID | P47869 |
| Regulation Type | |
| PubMed IDs | 16430927 |
| Citations | Atack JR, Pike A, Marshall G, Stanley J, Lincoln R, Cook SM, Lewis RT, Blackaby WP, Goodacre SC, McKernan RM, Dawson GR, Wafford KA, Reynolds DS: The in vivo properties of pagoclone in rat are most likely mediated by 5'-hydroxy pagoclone. Neuropharmacology. 2006 May;50(6):677-89. Epub 2006 Jan 20. |
| Groups | Investigational |
| Direct Classification | Naphthyridines |
| SMILES | CC(C)CCC(=O)CC1N(C(=O)C2=CC=CC=C12)C1=NC2=C(C=CC(Cl)=N2)C=C1 |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL2104745 |
